Fredholm BB. Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ. 2007;14:1315–23.
Mehta TR, Murala S, Thakkar MM. Adenosine. Cham: Springer International Publishing; 2022.
Borea PA, Gessi S, Merighi S, Vincenzi F, Varani K. Pharmacology of adenosine receptors: the state of the art. Physiol Rev. 2018;98:1591–625. https://doi.org/10.1152/physrev.00049.2017.
Layland J, Carrick D, Lee M, Oldroyd K, Berry C. Adenosine. JACC Cardiovasc Interv. 2014;7:581–91.
Camici M, Garcia-Gil M, Tozzi M. The inside story of adenosine. Int J Mol Sci. 2018;19:784.
PubMed PubMed Central Google Scholar
Yegutkin GG. Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochim Biophys Acta - Mol Cell Res. 2008;1783:673–94.
Robson SC, Wu Y, Sun X, Knosalla C, Dwyer K, Enjyoji K. Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation. Semin Thromb Hemost. 2005;31:217–33. https://doi.org/10.1055/s-2005-869527.
Picher M, Burch LH, Hirsh AJ, Spychala J, Boucher RC. Ecto 5′-nucleotidase and nonspecific alkaline phosphatase: two AMP-hydrolyzing ectoenzymes with distinct roles in human airways. J Biol Chem. 2003;278:13468–79. https://doi.org/10.1074/jbc.M300569200.
Young JD, Yao SYM, Baldwin JM, Cass CE, Baldwin SA. The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29. Mol Aspects Med. 2013;34:529–47. https://doi.org/10.1016/j.mam.2012.05.007.
Vecchio EA, White PJ, May LT. The adenosine A2B G protein-coupled receptor: recent advances and therapeutic implications. Pharmacol Ther. 2019;198:20–33. https://doi.org/10.1016/j.pharmthera.2019.01.003.
Burnstock G. Purine and purinergic receptors. Brain Neurosci Adv. 2018;2:239821281881749. https://doi.org/10.1177/2398212818817494.
Sheth S, Brito R, Mukherjea D, Rybak L, Ramkumar V. Adenosine receptors: expression, function and regulation. Int J Mol Sci. 2014;15:2024–52.
PubMed PubMed Central Google Scholar
Antonioli L, Fornai M, Blandizzi C, Pacher P, Haskó G. Adenosine signaling and the immune system: when a lot could be too much. Immunol Lett. 2019;205:9–15. https://doi.org/10.1016/j.imlet.2018.04.006.
Junger WG. Immune cell regulation by autocrine purinergic signalling. Nat Rev Immunol. 2011;11:201–12.
CAS PubMed PubMed Central Google Scholar
Fredholm BB. Physiological and pathophysiological roles of adenosine. Sleep Biol Rhythms. 2011;9:24–8. https://doi.org/10.1111/j.1479-8425.2010.00460.x.
Faas MM, Sáez T, de Vos P. Extracellular ATP and adenosine: the Yin and Yang in immune responses? Mol Aspects Med. 2017;55:9–19.
Arab S, Hadjati J. Adenosine blockage in tumor microenvironment and improvement of cancer immunotherapy. Immune Netw. 2019;19:1–19. https://doi.org/10.4110/in.2019.19.e23.
Barletta KE, Ley K, Mehrad B. Regulation of neutrophil function by adenosine. Arterioscler Thromb Vasc Biol. 2012;32:856–64. https://doi.org/10.1161/ATVBAHA.111.226845.
CAS PubMed PubMed Central Google Scholar
Cronstein BN, Levin RI, Belanoff J, Weissmann G, Hirschhorn R. Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells. J Clin Invest. 1986;78:760–70.
CAS PubMed PubMed Central Google Scholar
Sullivan GW, Lee DD, Ross WG, DiVietro JA, Lappas CM, Lawrence MB, et al. Activation of A2A adenosine receptors inhibits expression of α4/β1 integrin (very late antigen-4) on stimulated human neutrophils. J Leukoc Biol. 2004;75:127–34.
Baghbani E, Noorolyai S, Shanehbandi D, Mokhtarzadeh A, Aghebati-Maleki L, Shahgoli VK, et al. Regulation of immune responses through CD39 and CD73 in cancer: novel checkpoints. Life Sci. 2021;282:119826. https://doi.org/10.1016/j.lfs.2021.119826.
Sills TL, Azampanah A, Fletcher PJ. The adenosine A2A agonist CGS 21680 reverses the reduction in prepulse inhibition of the acoustic startle response induced by phencyclidine, but not by apomorphine and amphetamine. Psychopharmacology. 2001;156:187–93. https://doi.org/10.1007/s002130100777.
Haskó G, Pacher P. Regulation of macrophage function by adenosine. Arterioscler Thromb Vasc Biol. 2012;32:865–9. https://doi.org/10.1161/ATVBAHA.111.226852.
CAS PubMed PubMed Central Google Scholar
Sag D, Carling D, Stout RD, Suttles J. Adenosine 5′-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J Immunol. 2008;181:8633–41.
Yang L, Zhang Y, Yang L. Adenosine signaling in tumor-associated macrophages and targeting adenosine signaling for cancer therapy. Cancer Biol Med. 2024;21:1–17.
Devi VJ, Radhika A, Biju PG. Adenosine receptor activation promotes macrophage class switching from LPS-induced acute inflammatory M1 to anti-inflammatory M2 phenotype. Immunobiology. 2023;228:152362. https://doi.org/10.1016/j.imbio.2023.152362.
Silva-Vilches C, Ring S, Mahnke K. ATP and its metabolite adenosine as regulators of dendritic cell activity. Front Immunol. 2018;9:1–11. https://doi.org/10.3389/fimmu.2018.02581/full.
Ko MK, Shao H, Kaplan HJ, Sun D. CD73+ dendritic cells in cascading Th17 responses of experimental autoimmune uveitis-induced mice. Front Immunol. 2020;11:1–13. https://doi.org/10.3389/fimmu.2020.601272/full.
Panther E, Corinti S, Idzko M, Herouy Y, Napp M, la Sala A, et al. Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells. Blood. 2003;101:3985–90.
Novitskiy SV, Ryzhov S, Zaynagetdinov R, Goldstein AE, Huang Y, Tikhomirov OY, et al. Adenosine receptors in regulation of dendritic cell differentiation and function. Blood. 2008;112:1822–31.
CAS PubMed PubMed Central Google Scholar
Allard B, Longhi MS, Robson SC, Stagg J. The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets. Immunol Rev. 2017;276:121–44. https://doi.org/10.1111/imr.12528.
CAS PubMed PubMed Central Google Scholar
Longhi MS, Robson SC, Bernstein SH, Serra S, Deaglio S. Biological functions of ecto-enzymes in regulating extracellular adenosine levels in neoplastic and inflammatory disease states. J Mol Med. 2013;91:165–72. https://doi.org/10.1007/s00109-012-0991-z.
Garcia-Garcia L, Olle L, Martin M, Roca-Ferrer J, Muñoz-Cano R. Adenosine signaling in mast cells and allergic diseases. Int J Mol Sci. 2021;22:5203.
CAS PubMed PubMed Central Google Scholar
Matsuoka I, Yoshida K, Ito M. Purinergic regulation of mast cell function: P2X4 receptor-mediated enhancement of allergic responses. J Pharmacol Sci. 2022;150:94–9. https://doi.org/10.1016/j.jphs.2022.07.005.
Feng L, Cai Y, Zhu M, Xing L, Wang X. The yin and yang functions of extracellular ATP and adenosine in tumor immunity. Cancer Cell Int. 2020;20:110. https://doi.org/10.1186/s12935-020-01195-x.
CAS PubMed PubMed Central Google Scholar
Hegde S, Leader AM, Merad M. MDSC: markers, development, states, and unaddressed complexity. Immunity. 2021;54:875–84.
CAS PubMed PubMed Central Google Scholar
Li J, Wang L, Chen X, Li L, Li Y, Ping Y, et al. CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancer. Oncoimmunology. 2017;6:1–13. https://doi.org/10.1080/2162402X.2017.1320011.
Comments (0)